MAPS Canada furthers its mission by:

  • Providing evidence-based, honest public education about the risks and benefits of psychedelics.
  • Supporting scientific research into many aspects of psychedelics including treatments for medical conditions, neuroscience, creativity and spirituality.
  • Planning, conducting, and publishing scientific research of psychedelic medicines.
  • Developing psychedelics into prescription medicines.
  • Training psychedelic psychotherapists and working to establish a network of treatment centers that can provide this service in the context of professional best practices.